EN | UA
EN | UA

Help Support

Back

Efficacy of Statins for management of patients with NAFLD

NAFLD NAFLD
NAFLD NAFLD

This systematic review and meta-analysis was performed to explore the efficacy of Statins on biochemical and histological parameters in people suffering from non-alcoholic fatty liver disease (NAFLD).

See All

Key take away

In NAFLD patients, Statins can effectively lower liver enzymes and have a positive impact on liver histology.

Background

This systematic review and meta-analysis was performed to explore the efficacy of Statins on biochemical and histological parameters in people suffering from non-alcoholic fatty liver disease (NAFLD).

Method

Databases such as PubMed, Web of Science, and SCOPUS were comprehensively explored for clinical trials and observational studies assessing the effects of Statins on NAFLD onset and management. This search was performed regardless of statin type or dose, the length of treatment, or the techniques used to diagnose NAFLD (imaging or biopsy technique).

Result

Thirteen studies were identified. Tests of liver function and lipid profiles both showed remarkable improvements. Steatosis grade (standardized mean difference, SMD -1.73; I2 = 98%) and NAFLD activity score (SMD -1.09; I2 = 93%) both exhibited substantial decline.

Conclusion

The use of Statins was associated with a reduction in hepatic enzymes and improvement in liver histology in people having NAFLD.

Source:

Clinical Nutrition

Article:

Statins’ efficacy in non-alcoholic fatty liver disease: A systematic review and meta-analysis

Authors:

Chrysoula Boutari et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en ru ua
Try: